Condition

Breast Atypical Hyperplasia clinical trials and research

• 2Clinical trials
• 1Country

All recruiting trials (2)

• Using low dose tamoxifen with or without omega-3 fatty acids to reduce breast cancer risk

  This study is testing whether adding omega-3 fatty acids to low dose tamoxifen can help reduce the risk of breast cancer in overweight or obese postmenopausal women.

  Recruiting at 3 sites Phase 2 National Cancer Institute (NCI) · Kansas City, Kansas and 2 other locations · NCT06195306

• Comparing acolbifene and low dose tamoxifen to prevent breast cancer in high-risk premenopausal women

  This study is testing whether acolbifene or low dose tamoxifen can help prevent breast cancer in high-risk premenopausal women.

  Recruiting at 4 sites Phase 2 National Cancer Institute (NCI) · Duarte, California and 3 other locations · NCT05941520

Related topics

Quick answers

How many Breast Atypical Hyperplasia clinical trials are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in United States. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →